UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 11, 2004
Cellu Tissue Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
| 333-118829 |
| 06-1346495 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
|
|
|
|
|
3442 Francis Road Suite 220 Alpharetta, Georgia |
| 30004 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
|
|
|
|
|
Registrant’s telephone number, including area code (678)393-2651 |
|
| ||
|
|
|
|
|
(Former name or former address, if changed since last report.) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On October 11, 2004, Cellu Tissue Holdings, Inc. provided a release announcing its fiscal second quarter ended August 26, 2004 results and a reporting package for the three months and six months ended August 26, 2004 to the holders of its 9 3/4 % senior secured notes due 2010, as required by the indenture under which the notes were issued. A copy of the release and reporting package are attached hereto as Exhibit 99.1 and 99.2.
The information in this Form 8-K, including the accompanying exhibits, are being furnished hereunder and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
The following material is being furnished as exhibits to this Current Report on Form 8-K:
(c) Exhibits
99.1 Release, dated October 11, 2004, furnished pursuant to Item 2.02
99.2 Reporting Package for the three months and six months ended August 26, 2004, furnished pursuant to Item 2.02
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| Cellu Tissue Holdings, Inc. | ||
|
| (Registrant) | ||
|
|
| ||
Date: October 11, 2004 |
| By: | /s/ Dianne M. Scheu |
|
|
| Ms. Dianne M. Scheu | ||
|
| Senior Vice President, Finance and | ||
3
EXHIBIT INDEX
99.1 Release, dated October 11, 2004
99.2 Reporting Package for the three months
and six months ended August 26, 2004
4